{
    "2019-09-26": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Here's Why Sanofi (SNY) is Outperforming Its Industry Of Late",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "outperforming",
                        "industry"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Here's Why AstraZeneca (AZN) is Outperforming Its Industry",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "outperforming",
                        "industry"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Achillion's Danicopan Gets Breakthrough Therapy Tag for PHN",
                "features": {
                    "keywords": [
                        "Achillion",
                        "Danicopan",
                        "breakthrough",
                        "therapy",
                        "PHN"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Incyte Treats First Patient in Phase III Vitiligo Study",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Phase III",
                        "Vitiligo",
                        "study"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}